IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y

IQVIA Holdings Analytics Inc. IQV has reported impressive third-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.

Adjusted earnings were $3 per share, outpacing the Zacks Consensus Estimate by 1.4% and rising 5.6% on a year-over-year basis. Total revenues of $4.1 billion surpassed the consensus estimate by a slight margin and grew 5.2% from the year-ago quarter.

The IQV stock has gained 44.9% over the past six months, outperforming the 13.2% growth of the industry it belongs to and the 26.6% rise of the Zacks S&P 500 Composite.

IQVIA’s Quarterly Details

The Research and Development segment’s revenues were $2.3 billion, increasing 4.5% from the year-ago quarter and 3.4% on a constant-currency basis. The metric surpassed our estimate of $2.2 billion.

Revenues from the Technology and Analytics segment were $1.6 billion, growing 5% from the year-ago quarter and 3.3% on a constant-currency basis. The metric missed our projection of $1.7 billion.

Contract Sales and Medical Solutions revenues increased 16.1% on a year-over-year basis to $209 million and increased 13.9% on a constant-currency basis. The metric beat our estimation of $181.7 million.

Adjusted EBITDA for the third quarter of 2025 was $949 million, a 1.1% rise from the year-ago quarter and outpaced our anticipation of $945.3 million.

The company exited the quarter with cash and cash equivalents of $1.8 billion compared with $2 billion in the preceding quarter. Long-term debt (less current portion) was $15 billion compared with $15.4 billion at the end of the second quarter of 2025.

Net cash generated from operating activities was $908 million and the capital expenditure for the quarter was $136 million. The company generated a free cash flow of $772 million in the quarter.

IQV’s 2025 Guidance

For 2025, IQVIA updated its revenue guidance to $16.15-$16.25 billion from the preceding quarter’s view of $16.10-$16.30 billion. The mid-point ($16.20 billion) of the guided range is higher than the Zacks Consensus Estimate of $16.16 billion.

IQV updated its earnings per share outlook to $11.85-$11.95 from the preceding quarter’s view of $11.75-$12.05. The mid-point ($11.90) of the guided range is higher than the consensus estimate of $11.86.

IQVIA’s adjusted EBITDA view was updated to $3.775-$3.800 billion from the preceding quarter’s view of $3.750-$3.825 billion.

IQV carries a Zacks Rank #4 (Sell) at present.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Earnings Snapshot

Waste Connections WCN reported impressive third-quarter 2025 results.

Waste Connections’ adjusted earnings (excluding 33 cents from non-recurring items) of $1.44 per share surpassed the Zacks Consensus Estimate by 4.4% and increased 6.7% year over year. Revenues of $2.5 billion beat the consensus estimate marginally and grew 5.1% from the year-ago quarter.

Equifax Inc. EFX posted impressive third-quarter 2025 results.

EFX’s adjusted earnings were $2.04 per share, outpacing the Zacks Consensus Estimate by 5.7% and increasing 10.3% from the year-ago quarter. Total revenues of $1.5 billion surpassed the consensus estimate by 1.5% and grew 6.9% on a year-over-year basis.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research